Personalized dendritic cell-based tumor immunotherapy

Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL- Tumors

(2014) N. Larmonier et al.   JOURNAL OF IMMUNOLOGY

Killer dendritic cells and their potential for cancer immunotherapy

(2009) Nicolas Larmonier et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic cells from bench to bedside and back

(2009) G.J. Adema   IMMUNOLOGY LETTERS

Vaccines for lymphomas: Idiotype vaccines and beyond

(2008) Roch Houot et al.   BLOOD REVIEWS

Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells

(2008) Frank Grünebach et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

(2008) Tanja D. de Gruijl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic cell vaccination and immune monitoring

(2008) E. H. J. G. Aarntzen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen

(2008) R. Bos et al.   CANCER RESEARCH

Tumor-Associated MICA Is Shed by ADAM Proteases

(2008) I. Waldhauer et al.   CANCER RESEARCH

Dendritic Cells: A Critical Player in Cancer Therapy?

(2008) Anna Karolina Palucka et al.   JOURNAL OF IMMUNOTHERAPY

Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression

(2008) N. Larmonier et al.   JOURNAL OF LEUKOCYTE BIOLOGY

A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model

(2008) G. Li et al.   MOLECULAR CANCER THERAPEUTICS

The use of dendritic cells in cancer immunotherapy

(2007) Alessio Nencioni et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY